Thermo Fisher Vanquish™ UHPLC System

Overview

The Thermo Fisher Vanquish™ UHPLC System represents a benchmark in modern liquid chromatography architecture, engineered for ultra-high resolution, robustness, and operational consistency across demanding analytical workflows. Based on dual-gradient, low-dispersion fluidic design and integrated pressure management, the system operates on the fundamental principle of high-pressure liquid chromatography (HPLC) enhanced by sub-2-µm particle-packed column technology—enabling separations at pressures up to 150 MPa (22,000 psi). Its modular yet cohesively integrated platform delivers both the mechanical stability of a monolithic instrument and the configurability of a component-based system, supporting seamless coupling with mass spectrometry (MS), charged aerosol detection (CAD), or UV/Vis photodiode array (PDA) systems. Designed with ergonomic considerations—including a 25% reduced height versus prior-generation modular platforms—the Vanquish system improves accessibility for users across global laboratory environments while maintaining full compliance with ISO 9001 manufacturing standards and CE marking for in vitro diagnostic (IVD) and GLP/GMP-aligned applications.

Key Features

• High-pressure binary/quaternary gradient pumping with active solvent compressibility compensation, delivering flow precision ≤0.07% RSD and pressure ripple <0.1% at 1 mL/min.
• Autosampler with 8832-position capacity via stackable 96-well and 384-well plate support, featuring needle-in-loop injection, positive displacement metering, and ambient + refrigerated (4–10 °C) sample storage compartments.
• Column compartment with dual-mode temperature control: conductive heating/cooling (5–120 °C) and optional active pre-heating of mobile phase lines to minimize thermal mismatch and retention time drift.
• Optical detection modules incorporating LightPipe™ flow cell technology—reducing path-length dispersion and enabling high-sensitivity absorbance measurement with minimal band broadening at acquisition rates up to 200 Hz.
• Integrated system controller with embedded real-time diagnostics, predictive maintenance alerts, and hardware-level firmware validation to ensure traceability per FDA 21 CFR Part 11 requirements.

Sample Compatibility & Compliance

The Vanquish platform supports a broad range of sample matrices—including biologics (mAbs, ADCs, peptides), small-molecule pharmaceuticals, natural products, and environmental extracts—without requiring hardware modification. All fluidic pathways contacting samples or solvents are constructed from biocompatible materials (e.g., titanium, PEEK, sapphire, and electropolished stainless steel), ensuring compatibility with aggressive mobile phases (e.g., TFA, HFIP, high-pH ammonium carbonate) and minimizing metal-catalyzed degradation. The system conforms to ISO/IEC 17025 calibration traceability frameworks and supports audit-ready operation under GxP-regulated environments. Instrument qualification documentation (IQ/OQ/PQ) templates are provided, aligned with ASTM E2656 (Standard Guide for Qualification of Liquid Chromatography Systems) and USP Analytical Instrument Qualification.

Software & Data Management

Controlled via Thermo Scientific Chromeleon™ Chromatography Data System (CDS) 7.3 or later, the Vanquish integrates natively with enterprise LIMS and ELN platforms through OPC UA and RESTful API interfaces. Chromeleon provides role-based user access control, electronic signatures, full audit trail logging (including method parameter changes, sequence edits, and reprocessing events), and automated report generation compliant with ALCOA+ data integrity principles. Raw data files (.raw) are stored in vendor-neutral format with embedded metadata (instrument configuration, calibration history, environmental logs), facilitating long-term archival and regulatory submission readiness.

Applications

The Vanquish UHPLC system is routinely deployed in pharmaceutical quality control (QC) for assay and impurity profiling per ICH Q2(R2); in biopharmaceutical characterization for intact mass analysis, peptide mapping, and glycan profiling; in academic proteomics for high-throughput LC-MS/MS workflows; and in food safety labs for multi-residue pesticide screening. Its reproducible gradient formation, low carryover (<0.003%), and column-to-column retention time stability (<0.1% RSD over 100 injections) make it suitable for method transfer between R&D, QC, and contract testing laboratories.

FAQ

What is the maximum backpressure rating of the Vanquish pump system?

The system is rated for continuous operation at 150 MPa (22,000 psi), with built-in pressure monitoring and automatic shutdown protocols activated above 155 MPa.
Does the autosampler support low-volume injections below 1 µL?

Yes—precision syringe actuation and air-gap injection enable reproducible delivery from 0.01 µL to 100 µL, validated per USP with ≤1.5% RSD at 0.1 µL using standard test mixtures.
Is the column oven compatible with elevated temperatures for HILIC or SEC applications?

The oven maintains stable setpoints from 5 °C to 120 °C with ±0.1 °C accuracy, supporting high-temperature SEC for polymer analysis and high-T HILIC separations without gradient distortion.
Can the Vanquish be operated in unattended 24/7 mode?

Yes—hardware redundancy (dual power supplies, hot-swappable valves), self-diagnostics, and scheduled maintenance reminders enable extended unattended runs, validated under ISO/IEC 17025 Annex A.2 for routine QC throughput.
How is data integrity ensured during remote operation?

All remote sessions are authenticated via LDAP/Active Directory integration, encrypted using TLS 1.2+, and logged with timestamped operator ID, IP address, and action type—fully compliant with FDA 21 CFR Part 11 Subpart B electronic record requirements.